Around the world, work to improve our understanding of bleeding disorders and find new, improved ways of treating them is advancing all the time.

Research by the global pharmaceutical industry has already revolutionised the lives of people in many parts of the world through the development of manufactured ‘recombinant’ factor replacement treatment. As a result, young people diagnosed today can expect to lead a relatively normal and long life, with far less pain and disability than previous generations.

Focal points for current research include

Thanks to ongoing investment and expertise from the scientific research community, the future looks bright.

The Burden of Haemophilia

The Haemophilia Society worked with the University of Chester to plan, lead and deliver a…
Read more Read more

Research Collaborations

Please click on the relevant links below to read more about the research collaborations we…
Read more Read more

Initial Diagnosis Report

The Haemophilia Society conducted this research in order to highlight some of the challenges that…
Read more Read more